Image Analysis CRO: Advanced preclinical imaging solutions
At Imavita, we develop cutting-edge image analysis services as a CRO (Contract Research Organization) partner. Image analysis and imaging biomarker quantification enables pharmaceutical, biotechnology, and academic customers to obtain precise, reliable, and actionable data for drug development and research. We implemented a specific department equipped with advanced softwares and tools.
Image analysis in preclinical research
Image analysis is a critical step in extracting quantitative and qualitative insights from imaging data generated during preclinical studies. It helps researchers evaluate treatment efficacy, understand disease progression, and support decision-making with detailed imaging biomarkers.
Our image analysis services
As an expert image analysis CRO, we offer tailored solutions to meet the specific needs of preclinical studies with the following services:
Quantitative
analysis
analysis
Extraction of precise numerical data to assess, for example tumor volumes, tissue density, or signal intensity changes over time.
Qualitative
interpretation
interpretation
Advanced visualization techniques to better understand treatment effects and disease mechanisms or drugs pharmacokinetics.
Multimodal image integration
Combining imaging modalities such as optical imaging BLI, FRI, OCT, MRI, PET/CT, for comprehensive insights.
Biomarker discovery
Identification and validation of imaging biomarkers for drug efficacy, or disease characterization.
Customized reporting
Delivery of detailed, publication-ready reports with high-resolution images and statistical analyses.
Quantitative
analysis
analysis
Extraction of precise numerical data to assess, for example tumor volumes, tissue density, or signal intensity changes over time.
Qualitative
interpretation
interpretation
Advanced visualization techniques to better understand treatment effects and disease mechanisms or drugs pharmacokinetics.
Multimodal image integration
Combining imaging modalities such as optical imaging BLI, FRI, OCT, MRI, PET/CT, for comprehensive insights.
Biomarker discovery
Identification and validation of imaging biomarkers for drug efficacy, or disease characterization.
Customized reporting
Delivery of detailed, publication-ready reports with high-resolution images and statistical analyses.
Our advanced tools and collaborations for the quantification of imaging biomarkers and image analysis
Tools
In vivo imaging: Imalytics®, 3DSlicer®, Osirix® with in house developed plugins.
SPECT / CT / ultrasonography embedded softwares.
OCT proprietary segmentation tools.
QuPath, FiJi, napari based tools.
Targeted open or proprietary tools.
SPECT / CT / ultrasonography embedded softwares.
OCT proprietary segmentation tools.
QuPath, FiJi, napari based tools.
Targeted open or proprietary tools.
Resources & Collaborations
Collaborations with public and private labs (satellite imaging and specific image treatment).
Applications of our Image analysis CRO services
Our image analysis solutions support a wide range of preclinical research applications, including:
Dermatology
Oncology
Neurology
Osteo-articular
Cardiovascular
Infectious diseases
Study of drug disposition and pharmacokinetics (PK)
The benefits of working with Imavita in image analysis
Expertise in imaging
With years of experience in preclinical imaging, our team has supported numerous drug development projects across dermatology, osteo-articular and oncology.
Advanced technology
We utilize cutting-edge imaging platforms and analysis software to provide accurate, high-quality results.
Tailored solutions
Our skilled scientists are available to help you select endpoint-specific solutions and assist in designing studies and protocols.
Data integrity and compliance
Our workflows adhere to industry standards, ensuring data reliability and reproducibility.
Contact Imavita for reliable image analysis CRO services
